How Did Philadelphia’s VC Activity Fare in Q2? Actually, Pretty Great
After months of speculation that the VC market was changing after a wild 2021, it’s confirmed — deals are still historically high in 2022, but have declined from last year.
PitchBook and the National Venture Capital Association dropped their Q2 2022 PitchBook-NVCA Venture Monitor on Thursday, featuring new data showing that after deals peaked in late 2021 and early 2022, nationally, there was a slowdown in the second quarter of the year. Angel and seed stage funding was down, though less dramatically, as were other early-stage venture capital deals and late-stage VC.
Public offerings have also been affected over the last several months as many companies that had been prepping for IPOs are waiting out a recession.
“IPOs continued to be essentially nonexistent for VC-backed companies in 2022,” the report said, “with only 22 closed during the first half of the year, relative to 183 in 2021, and 108 in 2020.”
Read the full article at: technical.ly
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
